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Background: In cesarean section (c-sec) it is known that women receiving spinal anesthesia have decreased 
intraoperative blood loss compared to women receiving general anesthesia. However, we should always 
consider postoperative bleeding (postpartum bleeding) that may follow. The amount of postpartum bleeding 
can be substantial. Therefore, we sought to evaluate the effect of type of anesthesia retrospectively on intra- and 
postoperative blood loss by comparing the changes of postoperative Hb, Hct at c-sec.
Methods: We retrospectively compared the medical records of 287 elective c-sec patients. We excluded medical and 
obstetric conditions that may predispose such patients to increased blood loss. Subsequent detailed record analysis 
included 152 patients that received spinal anesthesia (group S), and 135 patients that received sevoflurane for general 
anesthesia (group G). 
Results: In comparison with the preoperative Hb, rates of Hb in the 1
st postoperative day in group S significantly 
decreased compared to group G, but there was no significant difference in decreasing rates of Hb in the 3
rd 
postoperative day between groups S and G. Estimated blood loss (EBL) of the intraoperative and operative day in 
group S was significantly lower compared to group G, but there was no significant difference in EBL of 1
st and 2
nd 
postoperative day between groups S and G. 
Conclusions: We conclude that group S had a decrease in blood loss between the intraoperative and operative day 
and there was no significant differences in postoperative blood loss compared with group G. (Korean J Anesthesiol 
2012; 62: 125-129)
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Introduction
In the 1950s, spinal anesthesia (SA) was regarded as the 
most dangerous anesthesia for pregnant women [1]. In recent 
times, however, it has been preferred in many countries, and 
instruments and drugs have been remarkably advanced. 
This is because SA tends to be superior to general anesthesia 
(GA) in airway management and intraoperative blood loss in 
the process of cesarean section (c-sec) [2-5]. However, there 
has been no comparison between the two in postoperative 
blood loss. For reference, the c-sec tends to cause one-month 
postoperative hemorrhage.
Hereat et al. made a comparison between women that 
underwent plain c-sec under sevoflurane-based GA (group G) 
and women that underwent 0.5% bupivacaine-based SA (group 
S) in postoperative hemoglobin (Hb) and hematocrit (Hct), 
and investigated how anesthesia types would influence the 
estimated blood loss (EBL) during and after surgery.
Materials and Methods
This study was conducted on patients who underwent 
c-sec between January 2005 and December 2009 at our 
hospital, excluding cases of internal fundamental diseases, 
pre  gnancy-related complications, anemia (Hb: 9.0 mg/dl 
and less), hydramnion, preterm deliveries, fetal deformities, 
malpresentation, uterine myomas, twin pregnancy, failed 
induction of labor and fetal distress syndromes. The surgeries 
were performed by two obstetricians having over ten years’ 
experience, and the research data were collected from the 
medical records of patients.
Out of 537 patients who underwent c-sec during the 
period, 287 were used as subjects in this study. The group 
S and the group G were composed of 152 and 135 patients 
respectively. On all the cases, c-sec were performed in the 
same procedure, i,e., an incision in the lower abdomen and a 
section in the uterine body. In the case of the group G, 0.2 mg 
of glycopyrrolate was administered by intramuscular injection 
30 minutes before admission to the operating room, and 0.5 
mg/kg of 1% lidocaine, 2 mg/kg of propofol and 0.6 to 0.8 mg/
kg of rocuronium were administered immediately before the 
surgery. The intraoperative anesthesia was maintained by 2 
L/min of nitrous oxide (N2O), 2 L/min of oxygen (O2) and 1 to 
1.5 vol% of sevoflurane. In the case of the group S, 8 to 10 mg 
of 0.5% bupivacaine and 15 to 20 μg of fentanyl were mixed 
and injected to block the anesthesia of dermatomes, T4 to T6. 
Ephedrine or atropine was injected in cases where hypotension 
or bradycardia occurred after SA. In all the groups, 100 μg of 
carbetocin was administered by intravenous injection after 
placental delivery. After undergoing the c-sec the patient was 
given an injection of 20 units of oxytocin mixed with 1,000 ml 
of 5% dextrose in water, and was given the fluid for one day. 
On the first day after surgery, a decision was made whether to 
transfuse blood or to inject ferric hydroxide sucrose complex 
(FHSC). FHSC was intravenously administered only to patients 
whose Hb was 10 mg/dl on the follow-up blood test and whose 
vital signs were within the normal range. However, this study 
did not address the time points of injections. The intraoperative 
transfusion was performed on patients whose preoperative 
Hb was 9 to 10 mg/dl and who were in an unstable condition 
hemodynamically at the anesthesiologist’s discretion.
From medical records, data on age, weight, birth history, 
preoperative intake of iron supplements, dose of fluid in 
intraoperative and the recovery room, dose of postoperative 
fluid in the ward, time required from the beginning of the 
surgery to fetal delivery (birth time), time required from the 
induction of anesthesia to the completion of surgery (surgery 
time), mean of systolic and diastolic blood pressure measured 
from the induction of anesthesia until 5 minutes after fetal 
delivery (intraoperative pressure), surgical history and 
intravenous injection of FHSC were collected. In addition, Hb 
and Hct were measured before the surgery (POD 0), on the first 
day after the surgery (POD 1), and on the third day after surgery 
(POD 3). Comparisons were made between POD 0 and POD 1 
levels, as well as between POD 1 and POD 3 levels. The patients 
who received transfusions were excluded from the calculation, 
because transfusions may affect Hb and Hct. Intraoperative 
blood losses were measured by various hands and thus had a 
large margin of error, hence EBL was calculated by the following 
formula in the light of hemodilution.
Maternal blood volume (MBV) = {0.75 × [(maternal height 
(inch) × 50) + (maternal weight (pound) × 25)] / 1,000} (L) [6]
EBL = MBV × ln (POD 0 Hb / POD 1 Hb) [7]
*POD 0-1 Hb DR = (POD 0 Hb - POD 1 Hb) / POD 0 Hb × 
100 (%)
*POD 0-1 Hb DR: The decreasing rate of Hb measured 
before and on the first day after the surgery
EBLs were calculated during (D-EBL) and immediately after 
the surgery (IO-EBL), on the basis of POD 0 Hb and POD 1 Hb. 
Likewise, POD 1 EBL and POD 2 EBL were calculated on the 
basis of POD 1 Hb and POD 3 Hb.
PASW (SPSS) 18 was used for statistical analysis, and the 
Levene’s test confirmed equal variance. The foregoing data on 
medical records were analyzed through the independent t test. 
Intergroup comparisons were conducted in relation to DR, EBL 
(independent t test), transfusional frequency (Chi-square test) 
and mean transfusion volume (Mann-Whitney U test).
All the values were within mean and standard deviation (SD) 127 www.ekja.org
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(mean ± SD). The significance level was defined as where the 
P value was less than 0.05.
Results
Table 1 shows factors that may affect the characteristics or 
blood losses of the groups. There were no significant intergroup 
differences in age, weight, fetal delivery time and surgery time. 
The S group showed significantly higher values in postoperative 
fluid dose and birth history, but showed a significantly higher 
value in intraoperative blood pressure.
In POD 0-1 Hb DR, POD 0-1 Hct DR and POD 0-3 Hct 
DR, the group S showed significantly lower values. In POD 0-3 
Hb, however, there was no significant intergroup difference 
(Table 2). Also, in POD 1-3 Hb DR and POD 1-3 Hct DR, no 
significant intergroup differences were observed (Table 2).
In relation to IO-EBL and D-EBL, the group S sowed 
significantly lower values. In D-1 EBL and D2-EBL, however, 
there were no significant intergroup differences (Table 3). In the 
S group, 8 (5.3%) out of 152 patients received intraoperative or 
postoperative transfusions, whereas in the group G, 15 (11.1%) 
out of 135 patients received them. However, there was no 
significant intergroup difference. Additionally, the groups did 
not show a significant difference in transfusion volume (Table 1).
Discussion
The group S had significantly lower values in relation to IO-
EBL and D-EBL, which can be explained by three reasons. First, 
in the case of the group S, blood is diluted in the process of fluid 
loading. In the case of SA, the fluid load is usually adjusted at 10 
to 15 ml/Kg in order to prevent hypotension. The injected fluid 
mostly runs through blood vessels until childbirth and placental 
delivery, and thus the erythrocyte loss decreases during the 
surgery [2]. In this study, the intraoperative fluid doses were 
1,170 ± 367.70 ml and 865.56 ± 463.22 ml in the group S and the 
group G respectively (P < 0.01).
Second, intraoperative hypotension can be a reason. 
Richman et al. [5] conducted meta-analyses on randomized 
Table 1. Selected Maternal Demographic Characteristics, Operative Time, Fluid Volume, Blood Pressure in Patients Undergoing Spinal 
Anesthesia versus General Anesthesia
Variable
Group SA
(n = 152)
 Group GA
(n = 135)
  Comparison
Age (yr)
Weight (kg)
Fluid volume (ml)
    Intraoperative   
    Postoperative
Time (min) 
    From incision to placenta delivery 
    From incision to skin suture          
BP (mmHg)
    Systolic
    Diastolic
Parity (numbers)
Transfusion (numbers)
Transfusion volume (ml)
Intravenous Fe
31.5 ± 3.8
68.8 ± 9.2
1,170.4 ± 367.7
5,088.8 ± 913.0
5.8 ± 2.2
39.7 ± 1.2
115.1 ± 13.4 
64.6 ± 9.7
1.9 ± 0.8
8 (5.3%)
282.9 ± 96.2
69 (47.9%)
32.7 ± 6.9
68.6 ± 9.3
865.6 ± 463.2
4,483.7 ± 941.0
5.4 ± 1.8
38.9 ± 1.4
145.3 ± 13.7
78.70 ± 10.0
1.75 ± 0.7
15 (11.1%)
350.5 ± 72.9 
61 (50.8%)
 NS
 NS
  P < 0.01 
  P < 0.01 
NS
NS
 P = 0.01 
 P < 0.01 
    P = 0.036
NS 
NS 
Values are the Mean ± SD. SA: spinal anesthesia, GA: general anesthesia, BP: blood pressure.
Table 2. Change of Hemoglobin and Hematocrit (Except Transfusion 
Group)
Variable
 Group SA
(n = 144)
 Group GA
(n = 120)
Comparison
DR Hb (POD 0-POD 1) (%)  
DR Hb (POD 0-POD 3) (%)
DR Hb (POD 1-POD 3) (%)
DR Hct (POD 0-POD 1) (%)
DR Hct (POD 0-POD 3) (%)
DR Hct (POD 1-POD 3) (%)
 9.9 ± 8.8  
 19.4 ± 10.0 
10.5 ± 7.7 
 8.3 ± 9.1 
17.6 ± 9.4
10.0 ± 7.8 
13.5 ± 9.4
21.4 ± 9.4 
 9.0 ± 7.7
 12.6 ± 10.7 
 20.0 ± 10.6
 8.3 ± 7.4
P = 0.001
NS
NS
 P < 0.001
P = 0.044
NS
Values are the Mean ± SD. SA: spinal anesthesia, GA: general 
anesthesia, DR: decreasing rate, Hb: hemoglobin, POD 0: 
preoperative, POD: postoperative day.
Table 3. Estimated Blood Loss in Patient Spinal Anesthesia Versus 
General Anesthesia (Except Transfusion Group)
Variable
Group SA
(n = 144)
Group GA
(n = 120)
Comparison
EBL (ml): D & IO
EBL (ml): POD 1, 2
EBL (ml): Total     
    570 ± 520
508 ± 417  
1,160 ±710     
790 ± 570  
594 ± 480
1,230 ±650    
P = 0.001
NS 
NS
Values are the Mean ± SD. SA: spinal anesthesia, GA: general 
anesthesia, EBL: estimated blood loss, D: During intraoperative, IO: 
immediately after surgery, POD 1, 2: 1
st, 2
nd postoperative day, Total: 
from operative day to 2
nd postoperative day. 128 www.ekja.org
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and controlled clinical trials to compare SA, epidural anesthesia 
(EA) and GA in intraoperative blood loss. Their meta-analyses 
were focused on all the cases of surgeries that involved GA or 
SA, e.g., c-sec, general surgical and orthopedic operations. The 
results showed that SA or EA was more effective to reduce blood 
loss compared to GA or the combination of GA and EA (SA ≤ 
EA < GA ≤ GA-EA). According to their explanation, SA caused 
sympathetic block and vasodilatation, and thus the venous 
return decreased. Then, as central venous pressure dropped, 
the peripheral vascular resistance became lower, and as a 
result, the blood pressure dropped. In addition, the reduction of 
the intraoperative blood loss reduced the need for transfusions 
and reduced the onset of transfusion-related diseases. Similarly 
in this study, systolic and diastolic blood pressures were 
significantly lower in the group S (systolic pressure: P = 0.01/
diastolic pressure: P < 0.01), which may affect EBL.
Lastly, uterine contraction may vary in different types of 
anesthesia. Guay [4] mentioned that in the process of c-sec, 
inhalation anesthetics caused uterine contractions that are 
closely related to postpartum hemorrhage. Various studies have 
been conductedon on this, and the results have showed that 
not only previous anesthetics such as halothane [8,9] but recent 
ones such as desflurane [8] and sevoflurane [9-11] hinder 
uterine contraction.
Turner et al. [12] extracted uterine muscles after c-sec and 
investigated how much sevoflurane and desflurane would 
hinder uterine contractions. They hinder the contractions of 
uterine muscles at 0.5 MAC, 1 MAC and 1.5 MAC, respectively, 
and they were similar in extent to each other.
Oxytocin is known to be a hormone that arouses uterine 
contraction [13]. In surgery, oxytocin is artificially injected 
to arouse uterine contraction, which means that it may be 
important to ascertain whether sevoflurane and desflurane 
hinder uterine contraction induced by oxytocin. Yildiz et al. 
[14] conducted experiments to evaluate this. Uterine muscles, 
extracted after placental delivery, were exposed to oxytocin, into 
which sevoflurane and desflurane were injected in different 
concentrations. The results showed that at 0.5 MAC, 1 MAC 
and 2 MAC, the two hindered the frequency and amplitude 
of uterine contraction induced by oxytocin in proportion to 
their doses. At 1 MAC, on the other hand, desflurane reduced 
the amplitude less than sevoflurane. Consequently, they 
recommended that sevoflurane and desflurane be used at 
0.5 MAC and 1 MAC respectively. In addition to inhalation 
anesthetics, intravenous anesthetics such as propofol, ketamine 
and midazolam hinder uterine contraction [15]. Also, there is a 
report that oxytocin prevents propofol from hindering uterine 
contraction [16]. In this study, 1 to 1.5 vol% of sevoflurane, 2 L/
min of nitrous oxide (N2O) and 2 L/min of oxygen (O2) were 
used to maintain general anesthesia, inter	alia, sevoflurane is 
deemed to hinder uterine contraction. Meanwhile, there are 
opinions that the intraoperative blood loss varies in different 
types of anesthesia.
Hood and Holubec [17] compared halothane-based GA 
and EA performed for c-sec, and reported that there was no 
significant difference in the two groups. Their study was con-
ducted retrospectively, and was intended for halothane similar 
to sevoflurane in the hindrance level to uterine contraction 
[18]. Moreover, their study was similar in subjects to this study. 
However, overall their study differs from this study. Their study 
focused on EA with the same doses of fluids, and calculated 
blood losses in actual measurement values. Due to the nature of 
a retrospective study, their calculation may not be accurate.
Wong et al. [19] compared two groups that underwent 
radical prostatectomies. They reported that there was no 
significant intergroup difference, and that blood losses were 
influenced by surgical skill and surgery time rather than 
anesthesia types, which presents a great contrast to this study. 
In the case of radical prostatectomy, the target nerve to be 
blocked is lower than that of c-sec; hence, the blood pressure is 
higher but the fluid load is lower. Therefore, their study could 
not deal with uterine contraction that influences hemorrhage. 
In this study, factors presented by Wong et al. [19] were taken 
into consideration to specifically to minimize variables in 
surgical skill and surgery time, and this study was limited to 
c-sec performed by two obstetricians having over ten years’ 
experience.
In relation to POD 0-1 Hb DR, the group S showed a signi-
fi  cantly lower value. But in relation to POD 0-3 Hb DR, there 
was no significant intergroup difference. This suggests a 
possi  bility that the two groups showed different blood losses 
during the surgery due to anesthesia type and other factors, 
but that the difference narrows with time after the surgery. 
There were no significant intergroup differences in POD 1-3 
Hb DR and POD 1-3 Hct DR, as shown in Table 2. It is known 
that after a c-sec, the blood loss usually reaches 200 to 300 ml 
[20,21]. In relation to IO-EBL and D-EBL, the group S showed 
significantly lower values. In POD 1- and POD 2 EBL, there were 
no significant intergroup differences. The situation was the 
same in POD 2 EBL (Table 3), which implies that the two groups 
are not different from each other in postpartum hemorrhage 
and hematologic recovery. It takes Hb 7 to 28 days to return to 
normal [22]. Thus, it is important to conduct blood tests on the 
7th and 28th day after surgery. In this study, Hb could not be 
measured immediately after the surgery, which means that the 
boundaries between IO-EBL and D-EBL are blurred. In case Hb 
is measured immediately after the surgery, it will be possible 
to separate D-EBL from IO-EBL and to identify the time point 
when the blood loss is not influenced by anesthesia type.
As shown in Table 2, the two groups did not show a signi-129 www.ekja.org
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ficant difference in POD 0-3 Hb DR. However in Hct DR, they 
showed a significant difference. The results may be related 
to hemodynamic accuracies of Hb and Hct. Ordinarily, Hb 
and Hct are used as indexes for anemia. In the case of Hct, it 
is influenced by erythrocyte size, plasma volume and fluid 
status. Thus, in the case of hemodilution, Hb is more effective to 
monitor the degree of anemia [23]. Likewise in this study, there 
was significant intergroup difference in POD 0-3 Hb DR, which 
implies that Hb reflects hematologic states more accurately.
Andrews et al. [2] reported that the blood loss was higher in 
GA than in SA, but was not serious enough to transfuse blood. To 
conclude, it was not significant clinically. Likewise in this study, 
there were no statistically significant differences in transfusional 
frequency and transfusion volume (Table 1). Meanwhile, this 
study was conducted retrospectively on the basis of medical 
records, and it was problematic to separate blood transfusions 
from FHSC injections. Accordingly, a prospective study should 
be conducted with the same standards for FHSC injections and 
blood transfusions are required.
In conclusion, POD 0-1 Hb DR was significantly lower in 
the group S than in the group G anesthetized by sevoflurane. In 
POD 0-3 Hb DR, however, there was no significant intergroup 
difference. IO-EBL and D-EBL were significantly lower in the 
group S, but in POD 1-EBL and POD 2-EBL, the groups did not 
show significant differences. Moreover, there were no significant 
differences from operative day to POD 2-EBL.
Taken together, it appears that SA is effective to reduce the 
blood loss during the c-sec and during the operative day, but 
that it is not different from GA two days after surgery.
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